Tabula Rasa HealthCare to acquire DoseMe

Tabula Rasa HealthCare announced it has executed a definitive agreement to acquire Brisbane, Australia based DoseMe. DoseMe is the developer of DoseMeRx, a precision dosing tool to help physicians and pharmacists accurately dose patients’ high-risk parenteral medications based on individual needs, resulting in improvements to mortality, risk, and patient outcomes. Already available in over 100 hospitals and infusion providers worldwide, DoseMeRx’s precision dosing capabilities will now be combined with TRHC’s proprietary medication risk mitigation, or MRM, technologies in order to enhance and accelerate medication safety solutions available in the hospital setting. TRHC expects the acquisition to close in Q1 of 2019, subject to customary closing conditions. TRHC expects to fund the acquisition through cash on hand and cash from operations, and from the use of its existing credit facility. Following the completion of the acquisition DoseMe will become part of TRHC’s CareVention technology and service division.
https://thefly.com/landingPageNews.php?id=2831141